Article Details

Nogapendekin Alfa Inbakicept/CAR-NK Wins FDA RMAT Designation for Lymphopenia ...

Retrieved on: 2025-03-05 16:41:23

Tags for this article:

Click the tags to see associated articles and topics

Nogapendekin Alfa Inbakicept/CAR-NK Wins FDA RMAT Designation for Lymphopenia .... View article details on hiswai:

Excerpt

The FDA has granted nogapendekin alfa inbakicept-pmln (Anktiva) and CAR-NK (PD-L1 t-haNK) regenerative medicine advanced therapy (RMAT) ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up